LEAP THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01. Other Events

On January 18, 2022, Leap Therapeutics, Inc. (the "Company") issued a press release entitled "Leap Therapeutics to Present Positive New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ASCO GI Cancers Symposium."

The full text of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference; provided, however that information on or connected to our website referenced in the Company's press release is expressly not incorporated by reference into or intended to be filed as a part of this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d)      Exhibits.



  Exhibit
   Number                                 Description
    99.1         Press Release dated January 18, 2022.
    104        Cover Page Interactive Data File. (Embedded within the Inline XBRL
               document.)




                                     - 2 -

© Edgar Online, source Glimpses